Shengjiang Xiexin decoction mitigates murine Clostridium difficile infection through modulation of the gut microbiota and bile acid metabolism
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Shengjiang Xiexin decoction mitigates murine Clostridium difficile infection through modulation of the gut microbiota and bile acid metabolism
Authors
Keywords
-
Journal
JOURNAL OF ETHNOPHARMACOLOGY
Volume -, Issue -, Pages 117384
Publisher
Elsevier BV
Online
2023-11-03
DOI
10.1016/j.jep.2023.117384
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Integrated serum pharmacochemistry and metabolomics reveal potential effective components and mechanisms of Shengjiang Xiexin decoction in the treatment of Clostridium difficile infection
- (2023) Yutao Cui et al. Heliyon
- The correlation between pharmacological activity and contents of eight constituents of Glycyrrhiza uralensis Fisch
- (2023) Rui He et al. Heliyon
- Clostridioides difficile Infection, Still a Long Way to Go
- (2021) Eleftheria Kampouri et al. Journal of Clinical Medicine
- Interleukin-22-mediated host glycosylation prevents Clostridioides difficile infection by modulating the metabolic activity of the gut microbiota
- (2020) Hiroko Nagao-Kitamoto et al. NATURE MEDICINE
- Microbiota insights in Clostridium difficile infection and inflammatory bowel disease
- (2020) C. Rodríguez et al. Gut Microbes
- Adaptogenic effects of Panax ginseng on modulation of immune functions
- (2020) Zubair Ahmed Ratan et al. Journal of Ginseng Research
- Fecal Microbiota of Toxigenic Clostridioides difficile-Associated Diarrhea
- (2019) Marta Hernández et al. Frontiers in Microbiology
- Herbal Medicines for Irinotecan-Induced Diarrhea
- (2019) Liu Tang et al. Frontiers in Pharmacology
- Total flavonoid aglycones extract in Radix Scutellariae induces cross-regulation between autophagy and apoptosis in pancreatic cancer cells
- (2019) Jiazhe Liu et al. JOURNAL OF ETHNOPHARMACOLOGY
- Probing Clostridium difficile Infection in Complex Human Gut Cellular Models
- (2019) Blessing O. Anonye et al. Frontiers in Microbiology
- Antibiotic Exposure Has Sex-Dependent Effects on the Gut Microbiota and Metabolism of Short-Chain Fatty Acids and Amino Acids in Mice
- (2019) Hongchang Gao et al. mSystems
- The current novel therapeutic regimens for Clostridium difficile infection (CDI) and the potentials of Traditional Chinese Medicine in treatment of CDI
- (2019) Yan Gao et al. CRITICAL REVIEWS IN MICROBIOLOGY
- Efficacy of oral administration of licorice as an adjunct therapy on improving the symptoms of patients with Parkinson's disease, A randomized double blinded clinical trial
- (2019) Peyman Petramfar et al. JOURNAL OF ETHNOPHARMACOLOGY
- Acetate coordinates neutrophil and ILC3 responses against C. difficile through FFAR2
- (2019) José Luís Fachi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Restoration of short chain fatty acid and bile acid metabolism following fecal microbiota transplantation in patients with recurrent Clostridium difficile infection
- (2018) Anna M. Seekatz et al. ANAEROBE
- Immune modulation of a lipid-soluble extract of Pinellia pedatisecta Schott in the tumor microenvironment of an HPV + tumor-burdened mouse model
- (2018) Haixia Huang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Tackling the recurrence of Clostridium difficile infection
- (2018) N. Petrosillo MEDECINE ET MALADIES INFECTIEUSES
- Hypervirulent Clostridium difficile ribotypes are CpG depleted
- (2018) Vinay Kamuju et al. Virulence
- Preventive Effects of a Chinese Herbal Formula, Shengjiang Xiexin Decoction, on Irinotecan-Induced Delayed-Onset Diarrhea in Rats
- (2017) Chao Deng et al. Evidence-based Complementary and Alternative Medicine
- Synthesis and Biological Evaluation of Bile Acid Analogues Inhibitory to Clostridium difficile Spore Germination
- (2017) Kristen L. Stoltz et al. JOURNAL OF MEDICINAL CHEMISTRY
- Simultaneous determination of 14 active constituents of Shengjiang Xiexin decoction using ultrafast liquid chromatography coupled with electrospray ionization tandem mass spectrometry
- (2017) Gang Peng et al. Acta Pharmaceutica Sinica B
- Equine faecal microbiota transplant: Current knowledge, proposed guidelines and future directions
- (2016) K. R. Mullen et al. EQUINE VETERINARY EDUCATION
- Phenolic composition, ascorbic acid content, and antioxidant capacity of Spanish jujube (Ziziphus jujube Mill.) fruits
- (2016) Aneta Wojdyło et al. FOOD CHEMISTRY
- The anti-inflammatory activity of licorice, a widely used Chinese herb
- (2016) Rui Yang et al. PHARMACEUTICAL BIOLOGY
- Resveratrol Attenuates Trimethylamine- N -Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota
- (2016) Ming-liang Chen et al. mBio
- Untargeted Metabolomics Reveals Dose-Response Characteristics for Effect of Rhubarb in a Rat Model of Cholestasis
- (2016) Cong-En Zhang et al. Frontiers in Pharmacology
- Berberine Blocks the Relapse of Clostridium difficile Infection in C57BL/6 Mice after Standard Vancomycin Treatment
- (2015) Zhi Lv et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fecal Microbiota Transplantation Eliminates Clostridium difficile in a Murine Model of Relapsing Disease
- (2015) Anna M. Seekatz et al. INFECTION AND IMMUNITY
- Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota
- (2015) Chih-Jung Chang et al. Nature Communications
- SMT19969 as a treatment for Clostridium difficile infection: an assessment of antimicrobial activity using conventional susceptibility testing and an in vitro gut model
- (2014) S. D. Baines et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Equine hyperimmune serum protects mice againstClostridium difficilespore challenge
- (2014) Weiwei Yan et al. Journal of Veterinary Science
- Microbiome Data Distinguish Patients with Clostridium difficile Infection and Non-C. difficile-Associated Diarrhea from Healthy Controls
- (2014) A. M. Schubert et al. mBio
- Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection
- (2014) Casey M. Theriot et al. Nature Communications
- Gut microbiota metabolism of l-carnitine and cardiovascular risk
- (2013) John R. Ussher et al. ATHEROSCLEROSIS
- Quantitative analysis of flavonoids, alkaloids and saponins of Banxia Xiexin decoction using ultra-high performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry
- (2013) Ying Wang et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- A review of the gastroprotective effects of ginger (Zingiber officinale Roscoe)
- (2013) Raghavendra Haniadka et al. Food & Function
- Vancomycin Treatment's Association with Delayed Intestinal Tissue Injury, Clostridial Overgrowth, and Recurrence of Clostridium difficile Infection in Mice
- (2012) C. A. Warren et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effects of probiotics and antibiotics on the intestinal homeostasis in a computer controlled model of the large intestine
- (2012) Ateequr Rehman et al. BMC MICROBIOLOGY
- Inhibitory effects of Scutellaria baicalensis extract on hepatic stellate cells through inducing G2/M cell cycle arrest and activating ERK-dependent apoptosis via Bax and caspase pathway
- (2011) Tai-Long Pan et al. JOURNAL OF ETHNOPHARMACOLOGY
- Comparative Metagenomic Study of Alterations to the Intestinal Microbiota and Risk of NosocomialClostridum difficile–Associated Disease
- (2010) Amee R. Manges et al. JOURNAL OF INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started